- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Cyclin-Dependent Kinase Inhibitor Proteins
Total 11887 results
-
Case Comprehensive Cancer CenterCompletedMetastatic Renal Cell CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Eighty-One Hospital of People's Liberation ArmyCompletedAdvanced Hepatocellular CarcinomaChina
-
Janssen Research & Development, LLCCompleted
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminatedChronic Myeloid Leukemia | Philadelphia PositiveItaly
-
Grupo Español de Investigación en NeurooncologíaPfizerCompletedGlioblastoma Multiforme (Grade IV) of CerebellumSpain
-
Brown UniversityWithdrawn
-
University of JenaLudwig-Maximilians - University of MunichTerminatedAcute Myeloid Leukemia, AdultGermany
-
Gilead SciencesCompletedDiabetic Kidney DiseaseUnited States
-
Translational Research Center for Medical Innovation...CompletedAnaplastic Thyroid CancerJapan
-
National Cancer Institute (NCI)Terminated
-
Peking UniversityUnknownEsophageal Squamous Cell CarcinomaChina
-
Yale UniversityCompletedAlopecia Areata | Alopecia Totalis | Alopecia UniversalisUnited States
-
PfizerCompletedPsoriasisUnited States, Denmark, Slovakia, Canada, Australia, Argentina, Bulgaria, Netherlands, United Kingdom, Brazil, Finland, Greece
-
Eisai Inc.Approved for marketing
-
Sarcoma Alliance for Research through CollaborationBristol-Myers SquibbCompletedChondrosarcoma | Chordoma | Hemangiopericytoma | Rhabdomyosarcoma | Sarcoma, Alveolar Soft Part | Epithelioid Sarcoma | Gastrointestinal Stromal Tumor (GIST) | Giant Cell Tumor of Bone | Sarcoma, Ewing's | Malignant Peripheral Nerve Sheath TumorsUnited States
-
GlaxoSmithKlineWithdrawn
-
Sichuan UniversityUnknown
-
GlaxoSmithKlineCompletedCancerKorea, Republic of, United States, United Kingdom
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.UnknownIntrahepatic CholangiocarcinomaChina
-
Fujian Cancer HospitalUnknownSquamous Cell Carcinoma
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.UnknownBiliary Tract CancerChina
-
National Taiwan University HospitalUnknownTriple Negative Breast CancerTaiwan
-
PETHEMA FoundationBristol-Myers Squibb; Dynamic SolutionsUnknownChronic Myeloid LeukemiaSpain
-
Eanm Research LtdWithdrawnMedullary Thyroid CarcinomaGermany
-
PfizerCompletedHemodialysis | End-Stage Renal DiseaseUnited States
-
PfizerCompletedHepatic InsufficiencyUnited States
-
University of Michigan Rogel Cancer CenterTerminatedMetastatic or Recurrent Squamous Cell Carcinoma of the EsophagusUnited States
-
AstraZenecaCompletedHead and Neck CancerHong Kong, Singapore
-
National Cancer Institute (NCI)Active, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...United States
-
Aveni FoundationWithdrawnCOVID-19 | Acute Respiratory Distress Syndrome | Cytokine Storm
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
H. Lee Moffitt Cancer Center and Research InstituteBayer; Pediatric Cancer FoundationCompleted
-
National Cancer Institute (NCI)Not yet recruiting
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Belgium, Canada, Australia, Brazil, China, Japan, Taiwan, Israel, France, Singapore, Germany, Italy, Spain, Thailand, Sweden, Turkey, Colombia, Costa Rica, Hong Kong, Poland, Chile, United Kingdom, New... and more
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Assiut UniversityActive, not recruitingPatients Diagnosed as Chronic Meyloid LeukemiaEgypt
-
H. Lee Moffitt Cancer Center and Research InstituteExelixisCompleted
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
CSL BehringChiltern International Inc.CompletedIncludes: Hereditary AngioedemaUnited States, Denmark, Germany, Switzerland
-
Tongji HospitalRecruitingHepatocellular Carcinoma | Effects of Immunotherapy | Programmed Cell Death 1China
-
TakedaNot yet recruiting
-
Merck Sharp & Dohme LLCRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel, Taiwan, United Kingdom, Chile, Canada, Japan, Brazil, China
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)RecruitingHead and Neck Cancer | Squamous Cell Carcinoma of Head and NeckUnited States
-
Zhongda HospitalNot yet recruitingOvarian Cancer, EpithelialChina
-
Atsushi KawakamiAbbVie GK.RecruitingRheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal UltrasoundJapan